A multiorgan donor cancer screening protocol: The Italian Emilia-Romagna region experience

Transplantation

Volumn 76, Issue 12, 2003, Pages 1695-1699

  Fiorentino, Michelangelo ^a   D'Errico, Antonia ^a   Corti, Barbara ^a   Casanova, Silvia ^a   Ridolfi, Lorenza ^b   Venturoli, Nicola ^b   Sestigiani, Elena ^b   Grigioni, Walter F ^a,c  

^a F Addarii Institute of Oncology   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Istituto Oncologico Addarii   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SCREENING; CHILD; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EFFUSION; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; ORGAN DONOR; PRIORITY JOURNAL; RISK; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CADAVER; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; HEALTH CARE RATIONING; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS; ITALY; MALE; NEOPLASMS; PATIENT SELECTION; SAFETY; TISSUE DONORS;

EID: 0346102448     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000092306.29395.96     Document Type: Article

References (19)

1. Conlon PJ, Smith SR. Transmission of cancer with cadaveric donor organs. J Am Soc Nephrol 1995; 6: 54.
2. Jonas S, Bechstein WO, Lemmens HP, et al. Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int 1996; 9: 426.
3. Loh E, Couch FJ, Hendricksen C, et al. Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. JAMA 1997; 277: 133.
4. Detry O, Honore P, Jacquet N, et al. Management of recipients of hepatic allografts harvested from donors with malignancy diagnosed shortly after transplantation. Clin Transplant 1998; 12: 579.
5. Stephens JK, Everson GT, Elliott CL, et al. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 2000; 70: 232.
6. Barrou B, Bitker MO, Delcourt A, et al. Fate of tubulopapillary adenoma transmitted by an organ donor. Transplantation 2001; 72: 540.
7. De Soyza AG, Dark JH, Parums DV, et al. Donor-acquired small cell lung cancer following pulmonary transplantation. Chest 2001; 120: 1030.
8. Sheil AG. Donor-derived malignancy in organ transplant recipients. Transplant Proc 2001; 33: 1827.
9. Kakar S, Burgart LJ, Charlton MR, et al. Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis. Hum Pathol 2002; 33: 435.
10. Kauffman HM, McBride MA, Cherikh WS, et al. Transplant tumor registry: donors with central nervous system tumors. Transplantation 2002; 73: 579.
11. Micheli A, Mugno E, Krogh V, et al. Cancer prevalence in European registry areas. Ann Oncol 2002; 13: 840.
12. Verdecchia A, Micheli A, Colonna M, et al. A comparative analysis of cancer prevalence in cancer registry areas of Florence, Italy and Spain. Ann Oncol 2002; 13: 1128.
13. Feng S, Buell JF, Cherick WS, et al. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation 2002; 74: 1657.
14. Council of Europe. International figures on organ donation and transplantation, 1996. Transplant News 1997; Vol. 2, No. 1.
15. Centro Nazionale Trapianti, Istituto Superiore di Sanita'. Attivita' di donazione, prelievo e trapianto in Italia, Anno 2001: i documenti, Vol. II. Bologna, Editrice Compositori 2002.
16. Kleihues P, Cavenee WK. Pathology and genetics of tumours of the nervous system. Lyon, IARC Press 2000.
17. Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 2000; 70: 1747.
18. Kauffman HM, McBride MA, Cherikh WS, et al. Transplant tumor registry: donor related malignancies. Transplantation 2002; 74: 358.
19. Birkeland SA, Storm HH. Risk for tumor and other disease transmission by transplantation: a population based study of unrecognised malignancies and other disease in organ donors. Transplantation 2002; 74: 1409.